A study of the drug GB001 to treat moderate to severe asthma

What we are studying

The purpose of this research study is to test the safety and effectiveness of a potential treatment drug called GB001, when added to the asthma medications you are currently prescribed.

Who is Eligible

  • All Genders
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • All Ethnicities
  • Ages 18 - 75

Eligibility Criteria

  • You are being asked to take part in this study because you have moderate to severe asthma that is not being fully controlled by the medicines you are currently taking. Asthma is a condition in which your airways narrow and swell and produce extra mucus. This can make breathing difficult and trigger coughing wheezing and shortness of breath. For some people with moderate to severe disease this can lead to an asthma attack.

What is involved

  • Informed Consent Review
  • Review of Medical History
  • Physical Examinations
  • Study Visits and Consultations
  • Surveys/Questionnaires
  • Laboratory and Imaging Tests Specimen Sample Collection
  • Diary/E-Diary Writing or Recordings
  • Use of Study Treatments or Placebo
  • Use of Study Health Plans
  • After Study Follow-Up Activities

Compensation

Compensation will be explained to each potential participant

Contact Information

Study Coordinator
Bob Hmieleski
Email
bhmieles@wakehealth.edu
Phone
(336) 713-8550
Principal Investigator
Wendy Moore

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.